Skip to content

Abivertinib

Abivertinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target tyrosine-protein kinase JAK3, epidermal growth factor receptor, and tyrosine-protein kinase BTK.
Trade Name
Common Name Abivertinib
Indication
Drug Class Tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors
Abivertinib
Get full access now